Rapid, automated, parallel quantitative immunoassays using highly integrated microfluidics and AlphaLISA

Zeta Tak For Yu, Huijiao Guan, Mei Ki Cheung, Walker M. McHugh, Timothy T. Cornell, Thomas P. Shanley, Katsuo Kurabayashi, Jianping Fu*

*Corresponding author for this work

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Immunoassays represent one of the most popular analytical methods for detection and quantification of biomolecules. However, conventional immunoassays such as ELISA and flow cytometry, even though providing high sensitivity and specificity and multiplexing capability, can be labor-intensive and prone to human error, making them unsuitable for standardized clinical diagnoses. Using a commercialized no-wash, homogeneous immunoassay technology ('AlphaLISA') in conjunction with integrated microfluidics, herein we developed a microfluidic immunoassay chip capable of rapid, automated, parallel immunoassays of microliter quantities of samples. Operation of the microfluidic immunoassay chip entailed rapid mixing and conjugation of AlphaLISA components with target analytes before quantitative imaging for analyte detections in up to eight samples simultaneously. Aspects such as fluid handling and operation, surface passivation, imaging uniformity, and detection sensitivity of the microfluidic immunoassay chip using AlphaLISA were investigated. The microfluidic immunoassay chip could detect one target analyte simultaneously for up to eight samples in 45 min with a limit of detection down to 10 pg mL -1. The microfluidic immunoassay chip was further utilized for functional immunophenotyping to examine cytokine secretion from human immune cells stimulated ex vivo. Together, the microfluidic immunoassay chip provides a promising high-throughput, high-content platform for rapid, automated, parallel quantitative immunosensing applications.

Original languageEnglish (US)
Article number11339
JournalScientific Reports
Volume5
DOIs
StatePublished - Jun 15 2015

Fingerprint

Microfluidics
Immunoassay
Immunophenotyping
Limit of Detection
Flow Cytometry
Enzyme-Linked Immunosorbent Assay
Cytokines
Technology
Sensitivity and Specificity

ASJC Scopus subject areas

  • General

Cite this

Yu, Zeta Tak For ; Guan, Huijiao ; Cheung, Mei Ki ; McHugh, Walker M. ; Cornell, Timothy T. ; Shanley, Thomas P. ; Kurabayashi, Katsuo ; Fu, Jianping. / Rapid, automated, parallel quantitative immunoassays using highly integrated microfluidics and AlphaLISA. In: Scientific Reports. 2015 ; Vol. 5.
@article{e7ca40f2167949918d941e2eab602f45,
title = "Rapid, automated, parallel quantitative immunoassays using highly integrated microfluidics and AlphaLISA",
abstract = "Immunoassays represent one of the most popular analytical methods for detection and quantification of biomolecules. However, conventional immunoassays such as ELISA and flow cytometry, even though providing high sensitivity and specificity and multiplexing capability, can be labor-intensive and prone to human error, making them unsuitable for standardized clinical diagnoses. Using a commercialized no-wash, homogeneous immunoassay technology ('AlphaLISA') in conjunction with integrated microfluidics, herein we developed a microfluidic immunoassay chip capable of rapid, automated, parallel immunoassays of microliter quantities of samples. Operation of the microfluidic immunoassay chip entailed rapid mixing and conjugation of AlphaLISA components with target analytes before quantitative imaging for analyte detections in up to eight samples simultaneously. Aspects such as fluid handling and operation, surface passivation, imaging uniformity, and detection sensitivity of the microfluidic immunoassay chip using AlphaLISA were investigated. The microfluidic immunoassay chip could detect one target analyte simultaneously for up to eight samples in 45 min with a limit of detection down to 10 pg mL -1. The microfluidic immunoassay chip was further utilized for functional immunophenotyping to examine cytokine secretion from human immune cells stimulated ex vivo. Together, the microfluidic immunoassay chip provides a promising high-throughput, high-content platform for rapid, automated, parallel quantitative immunosensing applications.",
author = "Yu, {Zeta Tak For} and Huijiao Guan and Cheung, {Mei Ki} and McHugh, {Walker M.} and Cornell, {Timothy T.} and Shanley, {Thomas P.} and Katsuo Kurabayashi and Jianping Fu",
year = "2015",
month = "6",
day = "15",
doi = "10.1038/srep11339",
language = "English (US)",
volume = "5",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",

}

Rapid, automated, parallel quantitative immunoassays using highly integrated microfluidics and AlphaLISA. / Yu, Zeta Tak For; Guan, Huijiao; Cheung, Mei Ki; McHugh, Walker M.; Cornell, Timothy T.; Shanley, Thomas P.; Kurabayashi, Katsuo; Fu, Jianping.

In: Scientific Reports, Vol. 5, 11339, 15.06.2015.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Rapid, automated, parallel quantitative immunoassays using highly integrated microfluidics and AlphaLISA

AU - Yu, Zeta Tak For

AU - Guan, Huijiao

AU - Cheung, Mei Ki

AU - McHugh, Walker M.

AU - Cornell, Timothy T.

AU - Shanley, Thomas P.

AU - Kurabayashi, Katsuo

AU - Fu, Jianping

PY - 2015/6/15

Y1 - 2015/6/15

N2 - Immunoassays represent one of the most popular analytical methods for detection and quantification of biomolecules. However, conventional immunoassays such as ELISA and flow cytometry, even though providing high sensitivity and specificity and multiplexing capability, can be labor-intensive and prone to human error, making them unsuitable for standardized clinical diagnoses. Using a commercialized no-wash, homogeneous immunoassay technology ('AlphaLISA') in conjunction with integrated microfluidics, herein we developed a microfluidic immunoassay chip capable of rapid, automated, parallel immunoassays of microliter quantities of samples. Operation of the microfluidic immunoassay chip entailed rapid mixing and conjugation of AlphaLISA components with target analytes before quantitative imaging for analyte detections in up to eight samples simultaneously. Aspects such as fluid handling and operation, surface passivation, imaging uniformity, and detection sensitivity of the microfluidic immunoassay chip using AlphaLISA were investigated. The microfluidic immunoassay chip could detect one target analyte simultaneously for up to eight samples in 45 min with a limit of detection down to 10 pg mL -1. The microfluidic immunoassay chip was further utilized for functional immunophenotyping to examine cytokine secretion from human immune cells stimulated ex vivo. Together, the microfluidic immunoassay chip provides a promising high-throughput, high-content platform for rapid, automated, parallel quantitative immunosensing applications.

AB - Immunoassays represent one of the most popular analytical methods for detection and quantification of biomolecules. However, conventional immunoassays such as ELISA and flow cytometry, even though providing high sensitivity and specificity and multiplexing capability, can be labor-intensive and prone to human error, making them unsuitable for standardized clinical diagnoses. Using a commercialized no-wash, homogeneous immunoassay technology ('AlphaLISA') in conjunction with integrated microfluidics, herein we developed a microfluidic immunoassay chip capable of rapid, automated, parallel immunoassays of microliter quantities of samples. Operation of the microfluidic immunoassay chip entailed rapid mixing and conjugation of AlphaLISA components with target analytes before quantitative imaging for analyte detections in up to eight samples simultaneously. Aspects such as fluid handling and operation, surface passivation, imaging uniformity, and detection sensitivity of the microfluidic immunoassay chip using AlphaLISA were investigated. The microfluidic immunoassay chip could detect one target analyte simultaneously for up to eight samples in 45 min with a limit of detection down to 10 pg mL -1. The microfluidic immunoassay chip was further utilized for functional immunophenotyping to examine cytokine secretion from human immune cells stimulated ex vivo. Together, the microfluidic immunoassay chip provides a promising high-throughput, high-content platform for rapid, automated, parallel quantitative immunosensing applications.

UR - http://www.scopus.com/inward/record.url?scp=84935864179&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84935864179&partnerID=8YFLogxK

U2 - 10.1038/srep11339

DO - 10.1038/srep11339

M3 - Article

C2 - 26074253

AN - SCOPUS:84935864179

VL - 5

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

M1 - 11339

ER -